{"id":12858,"date":"2024-09-08T12:23:40","date_gmt":"2024-09-08T10:23:40","guid":{"rendered":"https:\/\/valintermed.com\/?p=12858"},"modified":"2024-09-08T12:23:40","modified_gmt":"2024-09-08T10:23:40","slug":"vtorichnyy-sistemnyy-amiloidoz","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/secondary-systemic-amyloidosis\/","title":{"rendered":"Secondary systemic amyloidosis"},"content":{"rendered":"
<\/div>\n

Secondary systemic amyloidosis (SA) is a complex and potentially debilitating disease characterized by deposition of amyloid protein in various tissues and organs. Such deposits lead to dysfunction of the affected organs and systems, the clinical picture of which is characterized by multiple and varied symptoms. Secondary amyloidosis is often caused by chronic inflammatory processes, infections, autoimmune diseases, or other conditions that cause increased formation of serum amyloid A (SAA), the precursor of amyloid. This condition occurs secondary to the underlying disease and, therefore, requires a comprehensive approach to diagnosis, treatment, and monitoring.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n